Cardiac safety of extensively drug-resistant tuberculosis regimens including bedaquiline, delamanid and clofazimine.

Tadolini, Marina; Lingtsang, Rangjung Dolma; Tiberi, Simon; Enwerem, Martin; D'Ambrosio, Lia; Sadutshang, Tsetan Dorji; Centis, Rosella; Migliori, Giovanni Battista

Tadolini, Marina; Lingtsang, Rangjung Dolma; Tiberi, Simon; Enwerem, Martin; D'Ambrosio, Lia; Sadutshang, Tsetan Dorji; Centis, Rosella; Migliori, Giovanni Battista.

Afiliación

Tadolini M; Unit of Infectious Diseases, Dept of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy.
Lingtsang RD; These authors contributed equally.
Tiberi S; Delek Hospital, Dharamshala, India.
Enwerem M; These authors contributed equally.
D'Ambrosio L; Division of Infection, Barts Health NHS Trust, London, UK.
Sadutshang TD; These authors contributed equally.
Centis R; Amity Health Consortium, Johannesburg, South Africa.
Migliori GB; These authors contributed equally.

Eur Respir J ; 48(5): 1527-1529, 2016 11.

Article en En | MEDLINE | ID: mdl-27799401

Asunto(s)

Clofazimina; Tuberculosis Extensivamente Resistente a Drogas; Antituberculosos; Diarilquinolinas; Humanos; Nitroimidazoles; Oxazoles; Tuberculosis Resistente a Múltiples Medicamentos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Clofazimina / Tuberculosis Extensivamente Resistente a Drogas Límite: Humans Idioma: En Revista: Eur Respir J Año: 2016 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google